-$364.2K
Net Activity
Institutions Holding
17
Popularity Rank
#8590
Avg Weight
0.00%
Total Value
$459.4K
17 institutions currently hold CVKD, with 5 net buyers and 10 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Decreased
Based on recent trading activity
Net Selling Institutions
10
Net Buying Institutions
5
Top 5 by Value
+$147.9K
Total Buy Value
$283.8K
Total Sell Value
5
Net Buyers
10
Net Sellers
1
Filings (90d)
$148K
Total Est. Value
40K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Pham Quang X | 2026-06-15 | $148K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
2
Filings (14d)
Cadrenal Therapeutics announced that Chief Medical Officer James J. Ferguson III resigned on July 7, 2026, effective July 31. The company has started a search for his successor and is negotiating a separation agreement. Terms of the separation are not yet finalized.
View Full Filing (SEC EDGAR)Cadrenal Therapeutics raised approximately $3.0 million in a private placement by issuing pre-funded warrants and common warrants to an institutional investor. The warrants each cover up to 960,000 shares, with exercise prices of $0.0001 and $3.00 per share. Directors and officers agreed to a 60-day lock-up, and the company filed a registration rights agreement for the warrant shares.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter